EFFICACY AND SAFETY OF ACZ885 IN PATIENTS WITH THE FOLLOWING CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES: FAMILIAL COLD AUTOINFLAMMATORY SYNDROME, MUCKLE-WELLS SYNDROME, OR NEONATAL ONSET MULTISYSTEM INFLAMMATORY DISEASE: